SCHEMBL845285

SCHEMBL845285

CCC(=O)c1ccccc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccccc3C(=O)CC)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
PABPC1 P11940 1/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPK1 P28482 2/20 0.46
HTT P42858 1/20 0.46
TRPV1 Q8NER1 1/20 0.44
EP300 Q09472 1/20 0.43
CREBBP Q92793 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845929 0.96 GAA (0.48) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845007 0.88 PABPC1 (0.49) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845131 0.88 PABPC1 (0.49) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL844996 0.88 CYP2C9 (0.50) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845008 0.87 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19LMNAMAPK1
SCHEMBL10119504 0.87 GAA (0.42) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845312 0.85 GAA (0.60) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845350 0.84 MAPK1 (0.49) GAAPABPC1ALDH1A1CYP2C9CYP2C19
SCHEMBL845443 0.84 CYP2C9 (0.47) PABPC1ALDH1A1CYP2C9CYP2C19LMNA
SCHEMBL845257 0.84 TRPV1 (0.48) PABPC1ALDH1A1CYP2C9CYP2C19MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed